Sara Puertas

Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing

Sónia A. Melo, Alberto Villanueva, Cátia Moutinho et al. · Proceedings of the National Academy of Sciences · 2011 · 253 citations · Full text

Tumor Biology, Medicine, Cancer-specific Growth Inhibitor +14

Taking Advantage of Unspecific Interactions to Produce Highly Active Magnetic Nanoparticle−Antibody Conjugates

Sara Puertas, Pilar Batalla, María Moros et al. · ACS Nano · 2011 · 153 citations

Nanoparticles, Engineering, Biomedical Engineering +21

A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect

Paula López-Serra, Miguel Marcilla, Alberto Villanueva et al. · Nature Communications · 2014 · 113 citations · Full text

Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer

Hiroaki Taniguchi, Filipe V. Jacinto, Alberto Villanueva et al. · Oncogene · 2011 · 103 citations · Full text

Lurbinectedin (PM01183), a New DNA Minor Groove Binder, Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer

August Vidal, Clara Muñoz, María-José Guillén et al. · Clinical Cancer Research · 2012 · 96 citations